Enzolytics Inc (ENZC) Stock Corrects 40% From This Week Peak: But Why?

Last week the Enzolytics Inc (OTCMKTS:ENZC) stock had hit its peak, but since then the stock has corrected sharply and over the course of the past week, it has tanked by as much as 40%.

While that may be the case, it is also necessary for investors to keep in mind that since May 19, 2021, the Enzolytics stocks is still up by a handsome 90%. Earlier on in the week, the company announced that plans for taking its ITV-1 anti-HIV therapeutic product to clinical trials and for eventual distribution in Europe have been concluded.

However, more importantly, the company also announced that the product is going to be a source of significant revenues for Enzolytics in the future. The company added that the product is not only going to be a positive for humanity but will also be a major positive for its business. It is now going to be interesting to note if the Enzolytics stock can recover today.

Market Reaction:

On Thursday, ENZC stock was down 2.40% to $0.2010 with more than 42.20 million shares, compared to  its average volume of 40.32 million shares. The stock has moved within a range of $0.1821 – 0.2289 after opening the trade at $0.2030. Over the past 52-week, the stock has been trading within a range of $0.0002 – 0.9580.

Moving Averages

+/- EMA(20)0.21 (-4.76%)
+/- SMA(50)0.16 (+25.00%)
+/- SMA(200)0.16 (+25.00%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3
Classic0.13230.15720.17910.20400.22590.25080.2727
Fibonacci0.15720.17510.18610.20400.22190.23290.2508
Camarilla0.18810.19240.19670.20400.20530.20960.2139
Woodie0.13280.15740.17960.20420.22640.25100.2732
DeMark0.16820.20400.2150

Related Posts

About The Author